Inogen (INGN) Competitors

CeriBell (NASDAQ:CBLL) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, community ranking, dividends, risk and analyst recommendations.

Is CBLL or INGN more profitable?

CeriBell has a net margin of 0.00% compared to Inogen's net margin of -15.89%. CeriBell's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	N/A	N/A	N/A
Inogen	-15.89%	-27.38%	-16.77%

Do insiders and institutionals have more ownership in CBLL or INGN?

89.9% of Inogen shares are owned by institutional investors. 20.1% of CeriBell shares are owned by company insiders. Comparatively, 1.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in CBLL or INGN?

Inogen received 380 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 68.78% of users gave Inogen an outperform vote.

Company	Underperform	Outperform
CeriBell	Outperform Votes 10 100.00%	Underperform Votes No Votes
Inogen	Outperform Votes 390 68.78%	Underperform Votes 177 31.22%

Which has better valuation and earnings, CBLL or INGN?

CeriBell has higher earnings, but lower revenue than Inogen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$71.54M	8.73	N/A	N/A	N/A
Inogen	$339.96M	0.49	-$102.45M	-$1.15	-5.43

Does the media prefer CBLL or INGN?

In the previous week, CeriBell and CeriBell both had 3 articles in the media. CeriBell's average media sentiment score of 1.20 beat Inogen's score of 0.77 indicating that CeriBell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inogen	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend CBLL or INGN?

CeriBell presently has a consensus target price of $32.50, indicating a potential upside of 88.19%. Inogen has a consensus target price of $9.50, indicating a potential upside of 52.00%. Given CeriBell's stronger consensus rating and higher probable upside, equities research analysts plainly believe CeriBell is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

CeriBell beats Inogen on 10 of the 13 factors compared between the two stocks.